Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus

Ana Chumbe, Richard A. Urbanowicz, Kwinten Sliepen, Sylvie M. Koekkoek, Richard Molenkamp, Alexander W. Tarr, Jonathan K. Ball, Janke Schinkel*, Marit J. van Gils

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
10 Downloads (Pure)

Abstract

A better understanding of the antibody response during natural infection and the effect on disease progression and reinfection is necessary for the development of a protective hepatitis C virus (HCV) vaccine. The HCV pseudoparticle (HCVpp) system enables the study of viral entry and inhibition by antibody neutralization. A robust and comparable neutralization assay is crucial for the development and evaluation of experimental vaccines.With the aim of optimizing the HCVpp-murine leukaemia virus (MLV) system, we tested the neutralization of HCVpp-harbouring E1E2 from 21 HCV isolates representing 6 different genotypes by several monoclonal antibodies (mAbs). HCVpps are generated by expressing functional envelope glycoproteins (E1E2) onto pseudoparticles derived from env-deleted MLV. Adjustments of E1E2, gag-pol and luciferase plasmid ratios resulted in increased yields for most HCVpps and recovery of one non-infectious HCVpp. We simplified and improved the protocol to achieve higher signal/noise ratios and minimized the amount of HCVpps and mAbs needed for the detection of neutralization. Using our optimized protocol, we demonstrated comparable results to previously reported data with both diluted and freeze-thawed HCVpps.In conclusion, we successfully established a simplified and reproducible HCVpp neutralization protocol for studying a wide range of HCV variants. This simplified protocol provides highly consistent results and could be easily adopted by others to evaluate precious biological material. This will contribute to a better understanding of the antibody response during natural infection and help evaluate experimental HCV vaccines.

Original languageEnglish
JournalThe Journal of general virology
Volume103
Issue number11
DOIs
Publication statusPublished - 18 Nov 2022

Bibliographical note

Funding information:
This work was supported by the Netherlands Organization for Scientific Research (NWO) ZonMw (grant numbers 91719372 and 015.015.042 to J.S.),
and by Amsterdam UMC through an AMC fellowship (to M.J.v.G.) and an AMC PhD scholarship (to A.C.). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.

Fingerprint

Dive into the research topics of 'Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus'. Together they form a unique fingerprint.

Cite this